Clinical Trial Results: Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of GSK3965193 in healthy participants and individuals with chronic Hepatitis B was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• GSK3965193

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2026-06-16